Stock LGND LIGAND PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Ligand Pharmaceuticals Incorporated

Equities

LGND

US53220K5048

Market Closed - Nasdaq
Other stock markets
 21:00:00 07/05/2024 BST 		5-day change 1st Jan Change
73.22 USD +0.54% Intraday chart for Ligand Pharmaceuticals Incorporated +4.76% +2.52%
05-07 Transcript : Ligand Pharmaceuticals Incorporated, Q1 2024 Earnings Call, May 07, 2024
05-07 Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Posts Q1 Revenue $31M, vs. Street Est of $27.9M MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ligand Pharmaceuticals Appoints Scott Plesha to the Role of Chief Executive Officer
CI
Ligand Pharmaceuticals Incorporated Announces Management Appointments
CI
Ligand Pharmaceuticals Incorporated Appoints Martine Zimmermann to its Board of Directors
CI
Insider Sell: Ligand Pharmaceuticals
MT
Insider Sell: Ligand Pharmaceuticals
MT
Ligand Pharmaceuticals Names Todd Davis Chief Executive
MT
Ligand Pharmaceuticals Incorporated Announces the Resignation of John Higgins as Director, Effective December 31, 2022
CI
Ligand Pharmaceuticals Incorporated Announces CEO Changes
CI
Insider Sell: Ligand Pharmaceuticals
MT
Ligand Pharmaceuticals Incorporated Appoints Octavio Espinoza as Chief Financial Officer
CI
Ligand Pharmaceuticals Incorporated Announces Management Changes
CI
Ligand Pharmaceuticals Incorporated Appoints Jason Haas to its Board of Directors
CI
Ligand Pharmaceuticals Incorporated and Avista Public Acquisition Corp. II Announces Executive Changes
CI
Insider Sell: Ligand Pharmaceuticals
MT
Ligand Pharmaceuticals Incorporated Appoints Dr. Jennifer Cochran to its Board of Directors
CI
Insider Trends: Insider at Ligand Pharmaceuticals Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact
MT
Ligand Pharmaceuticals Incorporated Appoints Sarah Boyce to the Company's Board of Directors
CI
Ligand Pharmaceuticals Incorporated Announces Executive Changes
CI
Ligand Pharmaceuticals Incorporated Appoints Nancy Ryan Gray as Board of Director
CI
Christel Iffland Joins Ligand as Vice President, Antibody Technologies
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LGND Stock
  4. News Ligand Pharmaceuticals Incorporated
  5. Insiders